Skip to main content

Driving innovation in haematology

Haematology focuses on disorders of the blood, blood, and the coagulation system. This highly complex network transports oxygen, nutrients, and hormones, drives immune defence, and maintains haemostasis through platelets and clotting factors.

Haematological conditions span red and white blood cells, platelets, coagulation, and bone marrow - from inherited bleeding disorders such as haemophilia to benign cytopenias and malignant, cancer-related disease.

Haematology disease areas

Haemophilia A

Haemophilia A is a rare, inherited bleeding disorder caused by deficient or defective factor VIII activity. It results in impaired coagulation, leading to prolonged bleeding, spontaneous haemorrhages, and joint damage.

Haemophilia B

Haemophilia B is a rare, inherited bleeding disorder caused by deficient or defective factor IX activity. It leads to impaired coagulation, resulting in prolonged bleeding, spontaneous haemorrhages, and joint damage.

ITP

Immune thrombocytopenia

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterised by immune-mediated platelet destruction and impaired platelet production, leading to thrombocytopenia and an increased risk of bleeding.

PNH

Paroxysmal nocturnal haemoglobinuria

Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, acquired clonal disorder of the haematopoietic stem cell characterised by complement-mediated intravascular haemolysis, anaemia and an increased risk of thrombosis.

DLBCL

Diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma characterized by malignant proliferation of mature B-lymphocytes. It is the most common subtype of lymphoma, presenting with rapidly enlarging lymph nodes and systemic symptoms.

Myelofibrosis

Myelofibrosis is a rare myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, leading to impaired haematopoiesis, cytopenias, and extramedullary blood cell production.

NP-53810